OS Therapies OSTX Income Statement
| FY'25 | FY'24 | ||
|---|---|---|---|
| $16.36M+476% | $2.84M-11.8% | ||
| $12.34M+211% | $3.97M+254% | ||
| -$28.71M-321% | -$6.81M-56.9% | ||
| —— | $2.05M-40.5% | ||
| -$48.14K+97.7% | -$2.07M+40.0% | ||
| —— | —— | ||
| -$28.75M-224% | -$8.88M-14.0% | ||
| -$0.99+25.6% | -$1.33— | ||
| -$28.34M-316% | -$6.81M-57.0% | ||
| -$28.71M-321% | -$6.81M-56.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is OS Therapies profitable?
- OS Therapies is not currently profitable: it reported a net loss of $35.3M over the trailing twelve months.
- What is OS Therapies's earnings per share?
- OS Therapies's diluted EPS over the trailing twelve months is $-1.08.
- Where does OS Therapies's income statement data come from?
- Every line is extracted from OS Therapies's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.